ALLMedicine™ Acne Vulgaris Center

Jan 15th, 2021 - The use of high-frequency ultrasound for noninvasive assessment of skin during chemical peeling therapies may be a useful tool. To determine whether high-frequency ultrasound is a useful tool to noninvasive assessment of skin and evaluation therap...

Jan 11th, 2021 - Acne vulgaris is a worldwide condition that has a complex pathophysiology. The knowledge of this pathology is clear in its four classic principles based on the pilosebaceous unit; there exists hyperkeratinization of its duct, increase of sebum pro...

Jan 11th, 2021 - Acne fulminans is a rare complication of classic acne. Less than 200 cases have been reported. It usually affects adolescent males with pre-existing acne vulgaris. It is characterized by an acute eruption of numerous and large inflammatory nodules...

Jan 5th, 2021 - This phase 2, 12-week, multicenter, randomized, double-blind, active- and vehicle-controlled (VC), parallel-group trial assessed the efficacy and safety of silica encapsulated benzoyl peroxide BP (E-BP), two concentrations of silica encapsulated t...

Jan 5th, 2021 - Amzeeq (minocycline foam 4%) for topical treatment of acne vulgaris.|2021|Gupta AK,Bruce A,Vincent KD,Abramovits W,|

Oct 17th, 2019 - Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its novel AMZEEQTM (minocycline) topical foam, 4%. AMZEEQ, fo...

Oct 14th, 2019 - Acne vulgaris is the most prevalent chronic skin disease in the United States, affecting nearly 50 million people per year, mostly adolescents and young adults. Potential sequelae of acne, such as scarring, dyspigmentation, and low self-esteem, ma...

Oct 3rd, 2019 - The FDA recently approved Galderma’s topical retinoid cream, known as Aklief, for the treatment of acne vulgaris. Additionally, the company reported positive safety profiles for Aklief in two phase 3 clinical trials on acne of both the face and tr...

Nov 23rd, 2018 - Acne vulgaris, a chronic inflammatory disease of the pilosebaceous unit associated with socialisation and mental health problems, may affect more than 80% of teenagers. Isotretinoin is the only drug that targets all primary causal factors of acne;...

Nov 13th, 2018 - Acne vulgaris is an inflammatory disorder of pilosebaceous unit, which runs a chronic course and it is self-limiting. Acne vulgaris is triggered by Propionibacterium acnes in adolescence, under the influence of normal circulating dehydroepiandrost...

Jan 15th, 2021 - The use of high-frequency ultrasound for noninvasive assessment of skin during chemical peeling therapies may be a useful tool. To determine whether high-frequency ultrasound is a useful tool to noninvasive assessment of skin and evaluation therap...

Jan 13th, 2021 - Erythromycin Topical Gel USP, 2% is indicated for the topical treatment of acne vulgaris.

Jan 13th, 2021 - Clindamycin Phosphate Topical Solution, Clindamycin Phosphate Gel, and Clindamycin Phosphate Lotion are indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician...

Jan 11th, 2021 - Acne vulgaris is a worldwide condition that has a complex pathophysiology. The knowledge of this pathology is clear in its four classic principles based on the pilosebaceous unit; there exists hyperkeratinization of its duct, increase of sebum pro...

Jan 11th, 2021 - Acne fulminans is a rare complication of classic acne. Less than 200 cases have been reported. It usually affects adolescent males with pre-existing acne vulgaris. It is characterized by an acute eruption of numerous and large inflammatory nodules...

Oct 7th, 2020 - In the opinion of Lawrence F. Eichenfield, MD, recent advances in the medical treatment of acne make it "an exciting time" for treating patients with the condition. During the virtual annual Masters of Aesthetics Symposium, he highlighted the foll...

Oct 7th, 2020 - In the opinion of Lawrence F. Eichenfield, MD, recent advances in the medical treatment of acne make it "an exciting time" for treating patients with the condition. Trifarotene cream 0.005% (Aklief). This marks the first new retinoid indicated for...

Aug 26th, 2020 - The Food and Drug Administration has approved clascoterone 1% cream for the topical therapy of acne, providing a treatment with a novel mechanism of action for acne. Clascoterone is a topical androgen receptor inhibitor indicated for treatment of ...

Aug 26th, 2020 - The Food and Drug Administration has approved clascoterone 1% cream for the topical therapy of acne, providing a treatment with a novel mechanism of action for acne. Clascoterone is a topical androgen receptor inhibitor indicated for treatment of ...

Jul 23rd, 2020 - Acne vulgaris is a common chronic skin disease involving blockage and/or inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland). Responses to therapeutic agents for acne may vary in people of color, including i...